UniProt ID | MK01_MOUSE | |
---|---|---|
UniProt AC | P63085 | |
Protein Name | Mitogen-activated protein kinase 1 | |
Gene Name | Mapk1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 358 | |
Subcellular Localization | Cytoplasm, cytoskeleton, spindle. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm. Membrane, caveola . Associated with the spindle during prometaphase and metaphase (By similarity). PEA15-binding and phosphoryla | |
Protein Description | Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in respons to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity).; Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity.. | |
Protein Sequence | MAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAAAAGP ------CCHHHHCCH | 13.05 | - | |
27 | Phosphorylation | GPRYTNLSYIGEGAY CCCCCCCEEECCCCH | 19.44 | - | |
63 | S-nitrosocysteine | PFEHQTYCQRTLREI CCCCHHHHHHHHHHH | 2.21 | - | |
63 | S-nitrosylation | PFEHQTYCQRTLREI CCCCHHHHHHHHHHH | 2.21 | 20925432 | |
63 | Glutathionylation | PFEHQTYCQRTLREI CCCCHHHHHHHHHHH | 2.21 | 24333276 | |
108 | Phosphorylation | IVQDLMETDLYKLLK EEECHHHCCHHHHHH | 19.83 | - | |
111 | Phosphorylation | DLMETDLYKLLKTQH CHHHCCHHHHHHHCC | 11.47 | - | |
136 | Acetylation | YQILRGLKYIHSANV HHHHHHCHHHHHCCC | 45.01 | 22826441 | |
149 | Ubiquitination | NVLHRDLKPSNLLLN CCCCCCCCHHHEECC | 51.17 | 22790023 | |
149 | Acetylation | NVLHRDLKPSNLLLN CCCCCCCCHHHEECC | 51.17 | 22826441 | |
151 | Phosphorylation | LHRDLKPSNLLLNTT CCCCCCHHHEECCCC | 38.22 | 26239621 | |
157 | Phosphorylation | PSNLLLNTTCDLKIC HHHEECCCCCCEEEC | 28.86 | 26239621 | |
158 | Phosphorylation | SNLLLNTTCDLKICD HHEECCCCCCEEECC | 11.71 | 26239621 | |
159 | S-nitrosylation | NLLLNTTCDLKICDF HEECCCCCCEEECCC | 5.62 | 22178444 | |
159 | Glutathionylation | NLLLNTTCDLKICDF HEECCCCCCEEECCC | 5.62 | 24333276 | |
159 | S-nitrosocysteine | NLLLNTTCDLKICDF HEECCCCCCEEECCC | 5.62 | - | |
179 | Phosphorylation | ADPDHDHTGFLTEYV CCCCCCCCCHHHHHH | 35.37 | 22322096 | |
183 | Phosphorylation | HDHTGFLTEYVATRW CCCCCHHHHHHHHCC | 24.02 | 27087446 | |
185 | Phosphorylation | HTGFLTEYVATRWYR CCCHHHHHHHHCCCC | 7.08 | 27087446 | |
188 | Phosphorylation | FLTEYVATRWYRAPE HHHHHHHHCCCCCCE | 16.22 | 27087446 | |
191 | Phosphorylation | EYVATRWYRAPEIML HHHHHCCCCCCEEHH | 8.13 | 23608596 | |
200 | Phosphorylation | APEIMLNSKGYTKSI CCEEHHCCCCCCCCH | 24.40 | 23608596 | |
201 | Ubiquitination | PEIMLNSKGYTKSID CEEHHCCCCCCCCHH | 55.66 | 22790023 | |
244 | Phosphorylation | HILGILGSPSQEDLN HHHHHCCCCCHHHHH | 20.24 | 26643407 | |
246 | Phosphorylation | LGILGSPSQEDLNCI HHHCCCCCHHHHHHH | 48.15 | 26643407 | |
257 | Ubiquitination | LNCIINLKARNYLLS HHHHHHHHHHHHHHH | 40.59 | - | |
261 | Phosphorylation | INLKARNYLLSLPHK HHHHHHHHHHHCCCC | 11.94 | 29514104 | |
270 | Ubiquitination | LSLPHKNKVPWNRLF HHCCCCCCCCHHHCC | 55.25 | 27667366 | |
282 | Phosphorylation | RLFPNADSKALDLLD HCCCCCCHHHHHHHH | 19.88 | - | |
358 | Phosphorylation | RFQPGYRS------- CCCCCCCC------- | 35.77 | 27149854 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
27 | S | Phosphorylation | Kinase | SGK1 | Q9WVC6 | Uniprot |
183 | T | Phosphorylation | Kinase | MEK1 | Q02750 | PSP |
183 | T | Phosphorylation | Kinase | MEK1 | P31938 | PSP |
183 | T | Phosphorylation | Kinase | MEK1 | P29678 | PSP |
183 | T | Phosphorylation | Kinase | MEK1 | Q01986 | PSP |
183 | T | Phosphorylation | Kinase | MAP2K2 | Q63932 | Uniprot |
185 | Y | Phosphorylation | Kinase | LCK | P06240 | PSP |
185 | Y | Phosphorylation | Kinase | ERK2 | P63085 | PSP |
185 | Y | Phosphorylation | Kinase | MAPK1 | P63086 | GPS |
185 | Y | Phosphorylation | Kinase | MEK1 | Q02750 | PSP |
185 | Y | Phosphorylation | Kinase | MEK1 | P31938 | PSP |
185 | Y | Phosphorylation | Kinase | MEK1 | P29678 | PSP |
185 | Y | Phosphorylation | Kinase | MEK1 | Q01986 | PSP |
185 | Y | Phosphorylation | Kinase | MAP2K2 | Q63932 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | Map3k1 | P53349 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MK01_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KLF11_HUMAN | KLF11 | physical | 12006497 | |
P53_HUMAN | TP53 | physical | 10958792 | |
TOP2A_MOUSE | Top2a | physical | 10207078 | |
ELK1_MOUSE | Elk1 | physical | 11435472 | |
VIF_HV1B1 | vif | physical | 9792705 | |
VIF_HV1BR | vif | physical | 9792705 | |
VIF_HV1H2 | vif | physical | 9792705 | |
SQSTM_MOUSE | Sqstm1 | physical | 16517408 | |
CAN2_MOUSE | Capn2 | physical | 14993287 | |
4EBP1_MOUSE | Eif4ebp1 | physical | 8939971 | |
4EBP2_MOUSE | Eif4ebp2 | physical | 8939971 | |
ELK1_MOUSE | Elk1 | physical | 15767678 | |
MAP2_MOUSE | Metap2 | physical | 15544353 | |
MBP_MOUSE | Mbp | physical | 15544353 | |
FER_MOUSE | Fert2 | physical | 15567065 | |
PAXI_MOUSE | Pxn | physical | 14636584 | |
B2CL1_HUMAN | BCL2L1 | physical | 16282323 | |
ATF2_MOUSE | Atf2 | physical | 15192015 | |
MK06_MOUSE | Mapk6 | genetic | 21505187 | |
NANOG_MOUSE | Nanog | physical | 24793005 | |
KS6A3_MOUSE | Rps6ka3 | physical | 24793005 | |
ELK1_MOUSE | Elk1 | physical | 9687507 | |
TNR1A_MOUSE | Tnfrsf1a | physical | 15865443 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, ANDMASS SPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, ANDMASS SPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, ANDMASS SPECTROMETRY. | |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, ANDMASS SPECTROMETRY. | |
"Quantitative time-resolved phosphoproteomic analysis of mast cellsignaling."; Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,Kawakami T., Salomon A.R.; J. Immunol. 179:5864-5876(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, ANDMASS SPECTROMETRY. | |
"Identification of the regulatory phosphorylation sites inpp42/mitogen-activated protein kinase (MAP kinase)."; Payne D.M., Rossomando A.J., Martino P., Erickson A.K., Her J.-H.,Shabanowitz J., Hunt D.F., Weber M.J., Sturgill T.W.; EMBO J. 10:885-892(1991). Cited for: PHOSPHORYLATION AT THR-183 AND TYR-185, AND PARTIAL PROTEIN SEQUENCE. |